Base Molecular Resonance™ Technologies Receives $60.3 Billion IP Licensing Valuation Across 56 Global Use Cases

Landmark Analysis from ipCapital Group Confirms Massive Licensing Potential of BMRT’s Patented Technology Across Multiple Platforms. These 56 use cases represent a portion of the broader potential applications, and the valuation is limited to the US and EU markets, excluding the additional impact and value globally… Read More